In June 2014, France established a screening program for persons reporting exposure to the Cavu River during 2011 2013.
We have established a screening method for RBC vesicle shedding using the Ca2+ ionophore ionomycin which is a rapid and efficient method to promote vesiculation.
Based on this hypothesis, we established a screening system for the identification of genes that are specifically involved in mammosphere formation.
Previously, we established a screening system for inhibitors of ER stress-induced XBP1 activation and identified the new active small molecules trierixin and quinotrierixin.
To establish a screen for novel CHT inhibitors, we capitalized on the significantly elevated surface expression of the human transporter bearing alanine substitutions for two amino acids, L531 and V532, that constitute a strong dileucine-type endocytic sequence.
We further combine αMHC-H2B-mCh mice with the CAG-eGFP-anillin mouse line for unambiguous visualization of cell cycle progression and division of postnatal CMs and for establishing a screening assay for cell cycle-modifying substances.
Here, we aimed to establish a screening system for epimutagens using human induced pluripotent stem cells (hiPSCs), an in vitro model for early human embryos, to examine the individual and combined effects of environmental chemicals on the epigenetic status of human embryos/fetuses.
Further impetus comes from provisions in the FQPA and 1996 Safe Drinking Water Act Amendments for establishing a screening and testing program for potential risks from endocrine disruptors.
The combination of both techniques in order to establish a screening test procedure for the resistance of ferritic/martensitic (f/m) steels to neutron damage in terms of hardening requires consideration of a number of details.
In an effort to identify proteins with nonredundant function in erythropoiesis, we established a genetic screen for abnormal red cell production and survival in mutant mice generated by large-scale ENU mutagenesis (Arnold et al. 2012; Krieg et al. 2011).
In summary, we have established a method of screening for ES cell binding peptides by phage display and identified a novel peptide that specifically binds to ES cells.
